GGrantIndex
Sort

21,453 grants matching tuberculosis

Molecular Genetic Analysis of Mycobacterium Tuberculosis

$691,610
William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2019 · AI

DISSEMINATED TUBERCULOSIS IN HIV INFECTION

$691,436
Dartmouth College · R01 · FY2000 · AI

Bone health in perinatally HIV-infected South African children on antiretrovirals

$691,417
Stephen M Arpadi · Columbia University Health Sciences · R01 · FY2015 · HD

Genetic and metabolic determinants of multiple drug resistance in tuberculosis

$691,268
Megan B Murray · Brigham And Women'S Hospital · U19 · FY2009 · AI

Inhaled tigecycline therapy for pulmonary M. abscessus infections

$691,193
Mercedes Gonzalez-Juarrero · Colorado State University · R01 · FY2023 · AI

Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations

$690,941
Lawrence Kwong · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · HG

Development and Testing of New Tuberculosis Vaccines

$690,878
Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2008 · AI

Tuberculosis and T cell Recognition

$690,876
Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · AI

Longitudinal Studies of HIV-Associated Lung Infections and Complications

$690,775
Kristina Anne Crothers · University Of Washington · R01 · FY2010 · HL

Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia

$690,762
Heather L Wipfli · University Of Southern California · U01 · FY2021 · CA

Proteogenomics of dysregulated protein interaction networks in MTB infection

$690,731
W. Henry Henry Boom · Case Western Reserve University · R01 · FY2012 · HL

Admixture Mapping of Sarcoidosis Genes in African American

$690,681
Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2011 · HL

Addressing Research Gaps to Optimize Dolutegravir-based ART in Children and Adolescents

$690,567
Awewura Jacob Kwara · University Of Florida · R01 · FY2024 · AI

Expanding access and impact of tuberculosis preventive therapy: Community-friendly delivery and monitoring of TPT to improve uptake and reduce TB transmission

$690,538
Adrienne E Shapiro · University Of Washington · R01 · FY2025 · AI

Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection

$690,151
John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2019 · AI

PS05-003, TUBERCULOSIS ELIMINATION AND LABORATORY

$690,151
Veda M Latin · Public Health Services · U52 · FY2008 · PS

PS05-003, TUBERCULOSIS ELIMINATION AND LABORATORY

$690,151
Veda M Latin · Public Health Services · U52 · FY2009 · PS

Drugs targeting persistent Mycobacterium Tuberculosis

$689,918
William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2013 · AI

The Warburg effect and host immune response in tuberculosis

$689,591
Lanbo Shi · Rbhs-New Jersey Medical School · R01 · FY2020 · AI

Increasing Involvement of MSM in the Continuum of Care in Kazakhstan

$689,338
Elwin Wu · Columbia Univ New York Morningside · R01 · FY2017 · DA

Therapeutic potential of mycobacteriophage LysB against Mycobacterium abscessus infections

$689,051
Anil Kumar Ojha · Wadsworth Center · R01 · FY2025 · AI

Novel Combination Adjuvant for Eliciting Systemic and Mucosal CD8 T Cell Memory

$689,029
Marulasiddappa Suresh · University Of Wisconsin-Madison · U01 · FY2020 · AI

Mechanism Based Inhibition of M Tuberculosis Enzymes

$688,982
Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2005 · AI

HIV/AIDS International Training Program

$688,868
Christopher C. Whalen · Case Western Reserve University · D43 · FY2011 · TW

Necrosis in Pulmonary TB granulomas: dynamics, mechanisms, and therapies

$688,810
Igor Kramnik · Boston University Medical Campus · R01 · FY2025 · HL